Shots: Roche & Vaccibody collaborated to assess the combination of VB10.16 + Tecentriq in P-II, for 50 patients with advanced cervical cancer to evaluate its safety, tolerability, immunogenicity and efficacy […]readmore
Tags : Agreeemnt
Shots: iPS Academia Japan to receive payments from Thyas. Thyas to get exclusive patent rights for production and usage of iPS cell-derived T cells, with non-exclusive rights for its development […]readmore
Shots: Glenmark to receive upfront, milestones and royalties on sales from Yuhan. Yuhan to get exclusive commercialization rights for Glenmark’s Ryaltris in South Korea Yuhan will be responsible for its […]readmore